Nov 14 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' ( SRPT ) gene therapy Elevidys that includes its most serious safety warning and restricts use of the treatment to walking patients 4 years of age and older with Duchenne muscular dystrophy. ...

02:10 PM EST, 11/14/2025 (MT Newswires) -- Cosa Resources ( COSAF ) on Friday upsized a commercially reasonable efforts private-placement offering to $7.5 million, up from its prior $5-million target. The offering now consists of the issuance of up to 11.5-million hard dollar units at $0.26 apiece, up to 7.5-million charity flow-through units at $0.398 per Charity FT unit, and...

02:06 PM EST, 11/14/2025 (MT Newswires) -- AtkinsRealis Group's ( SNCAF ) nuclear business continues to outpace expectations and appears well-positioned to capture new build opportunities over the intermediate-to-long term, notes BMO. Even though the Engineering Services business experienced some challenges in 2025, growth is still expected to re-accelerate in the coming quarters, writes analyst Devin Dodge. Layering in a...

NEW YORK, NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Alussa Energy Acquisition Corp. II (the “Company”) announced today that it consummated its initial public offering of 28,750,000 units at $10.00 per unit including the issuance of 3,750,000 units as a result of the underwriter’s full exercise of its over-allotment option. The offering resulted in gross proceeds to the Company...